Lyra Therapeutics Ownership | Who Owns Lyra Therapeutics?


OverviewForecastRevenueFinancialsChart

Lyra Therapeutics Ownership Summary


Lyra Therapeutics is owned by 36.63% institutional investors, 0.67% insiders, and 62.70% retail investors. Sabby management is the largest institutional shareholder, holding 9.32% of LYRA shares. iShares Russell 2000 ETF is the top mutual fund, with 3.38% of its assets in Lyra Therapeutics shares.

LYRA Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockLyra Therapeutics36.63%0.67%62.70%
SectorHealthcare Stocks 488.17%11.08%-399.26%
IndustryBiotech Stocks 306.59%11.10%-217.69%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Sabby management125.73K9.32%$1.13M
Blackrock2.83M4.42%$783.05K
Morgan stanley811.75K1.27%$224.61K
Goldman sachs group555.51K0.85%$114.66K
State of wisconsin investment board10.50K0.78%$94.08K
Caption management246.60K0.39%$68.23K
Bnp paribas arbitrage, snc244.92K0.37%$50.55K
Susquehanna group, llp103.43K0.16%$21.35K
Fmr99.79K0.15%$20.60K
Bank of america corp /de/86.46K0.14%$23.86K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Sabby management125.73K2.04%$1.13M
Signature resources capital management400.000.00%$3.58K
Caption management246.60K0.00%$68.23K
Valley national advisers500.000.00%$4.00K
State of wisconsin investment board10.50K0.00%$94.08K
National bank of canada /fi/---
Price t rowe associates inc /md/---
Renaissance---
Proshare advisors---
Prelude capital management---

Top Buyers

HolderShares% AssetsChange
Blackrock2.83M-2.68M
Morgan stanley811.75K-747.35K
Caption management246.60K0.00%246.60K
Bnp paribas arbitrage, snc244.92K-244.92K
Sabby management125.73K2.04%125.73K

Top Sellers

HolderShares% AssetsChange
Perceptive advisors---12.76M
Blackrock funding, inc. /de---3.02M
Nantahala capital management---2.82M
Point72 asset management---2.74M
Vr adviser---2.58M

New Positions

HolderShares% AssetsChangeValue
Caption management246.60K0.00%246.60K$68.23K
Bnp paribas arbitrage, snc244.92K-244.92K$50.55K
Sabby management125.73K2.04%125.73K$1.13M
State of wisconsin investment board10.50K0.00%10.50K$94.08K
Valley national advisers500.000.00%500.00$4.00K

Sold Out

HolderChange
Farther finance advisors-38.00
Sterling capital management-88.00
Eversource wealth advisors-343.00
Jones financial companies lllp-500.00
Nisa investment advisors-500.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202529-49.12%493,995-98.07%362.54%10-50.00%19-
Mar 31, 20255-90.74%15,783,037-41.30%241.42%1-96.43%1-91.67%
Dec 31, 202454-12.90%26,885,924-17.35%411.66%28-12.50%12-14.29%
Sep 30, 20246115.09%32,528,511-0.62%491.90%3110.71%147.69%
Jun 30, 202453-35.37%32,730,433-28.15%510.61%28-47.17%13-7.14%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
iShares Russell 2000 ETF44.78K3.38%-
Vanguard US Total Market Shares ETF992.54K1.51%2.00
Vanguard Total Stock Mkt Idx Inv19.43K1.20%-424.00
iShares Russell 2000 Growth ETF408.38K0.62%-
Fidelity Small Cap Index6.33K0.40%-
Vanguard Institutional Extnd Mkt Idx Tr6.26K0.39%-2.85K
Fidelity Extended Market Index5.44K0.34%-14.00
Vanguard Russell 2000 ETF4.83K0.30%24.00
Russell 3000 Screened Index Composite186.70K0.29%186.70K
Spartan Total Market Index Pool E140.13K0.21%-

Recent Insider Transactions


DateNameRoleActivityValue
Jul 10, 2025Palasis Maria President & CEOSell$13.94K
Jul 10, 2025Cavalier Jason Chief Financial OfficerSell$6.09K
Nov 10, 2023Waksal Harlan Executive ChairBuy$74.09K
May 31, 2023NBVM GP, LLC-Buy$981.37K
May 31, 2023NBVM GP, LLC-Buy$2.92M

Insider Transactions Trends


DateBuySell
2025 Q2--
2025 Q1--
2024 Q4--
2024 Q2--
2024 Q1--

LYRA Ownership FAQ


Who Owns Lyra Therapeutics?

Lyra Therapeutics shareholders are primarily institutional investors at 36.63%, followed by 0.67% insiders and 62.70% retail investors. The average institutional ownership in Lyra Therapeutics's industry, Biotech Stocks , is 306.59%, which Lyra Therapeutics falls below.

Who owns the most shares of Lyra Therapeutics?

Lyra Therapeutics’s largest shareholders are Sabby management (125.73K shares, 9.32%), Blackrock (2.83M shares, 4.42%), and Morgan stanley (811.74K shares, 1.27%). Together, they hold 15.01% of Lyra Therapeutics’s total shares outstanding.

Does Blackrock own Lyra Therapeutics?

Yes, BlackRock owns 4.42% of Lyra Therapeutics, totaling 2.83M shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 783.06K$. In the last quarter, BlackRock increased its holdings by 2.68M shares, a 1762.82% change.

Who is Lyra Therapeutics’s biggest shareholder by percentage of total assets invested?

Sabby management is Lyra Therapeutics’s biggest shareholder by percentage of total assets invested, with 2.04% of its assets in 125.73K Lyra Therapeutics shares, valued at 1.13M$.

Who is the top mutual fund holder of Lyra Therapeutics shares?

iShares Russell 2000 ETF is the top mutual fund holder of Lyra Therapeutics shares, with 3.38% of its total shares outstanding invested in 44.78K Lyra Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools